Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.

BACKGROUND Left ventricular assist devices (LVADs) are increasingly used as long-term therapy for end-stage heart failure patients. We compared the prevalence of aortic insufficiency (AI) after HeartMate II (HMII) vs HeartMate XVE (HMI) support and assessed the role of aortic root diameter and aortic valve opening in the development of AI. METHOD Pre-operative and post-operative echocardiograms of 93 HMI and 73 HMII patients who received implants at our center between January 2004 and September 2009 were retrospectively reviewed. After excluding patients with prior or concurrent surgical manipulation of the aortic valve, with baseline AI, or without baseline echoes, 67 HMI and 63 HMII patients were studied. AI was deemed significant if mild to moderate or greater. Pathology reports were reviewed for 77 patients who underwent heart transplant. RESULTS AI developed in 4 of 67 HMI (6.0%) and in 9 of 63 HMII patients (14.3%). The median times to AI development were 48 days for HMI patients and 90 days for HMII patients. For patients who remained on device support at 6 and 12 months, freedom from AI was 94.5% and 88.9% in HMI patients and 83.6% and 75.2% in HMII patients (log rank p = 0.194). Aortic root diameters, as determined by echocardiography for the patients with AI, trended to be larger at baseline (3.43 ± 0.43 vs 3.15 ± 0.40; p = 0.067) and follow-up (3.58 ± 0.54 vs 3.29 ± 0.50; p = 0.130) compared with those who did not have AI. Aortic root circumferences were assessed directly by a pathologist in those patients who underwent transplant and were significantly larger in HMII patients who had developed AI compared with those patients who did not (8.44 ± 0.89 vs 7.36 ± 1.02 cm; p = 0.034). Lastly, AI was more common in patients whose aortic valve did not open (11 of 26 vs 1 of 14; p = 0.03). CONCLUSION Aortic insufficiency occurs frequently in patients who receive continuous-flow support with a HMII LVAD, and may be associated with aortic root diameter enlargement and aortic valve opening. These findings warrant a more thorough preoperative patient evaluation and additional studies to investigate the factors, that may be associated with AI development.

[1]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[2]  Mark S. Slaughter,et al.  Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection , 2007, Circulation.

[3]  Andrew Boyle,et al.  Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. , 2008, The Annals of thoracic surgery.

[4]  F. Pagani.  Continuous-flow rotary left ventricular assist devices with "3rd generation" design. , 2008, Seminars in thoracic and cardiovascular surgery.

[5]  P. Kligfield,et al.  Aortic root dilatation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function. , 1987, Annals of internal medicine.

[6]  W. Edwards,et al.  Surgical pathology of pure aortic insufficiency: a study of 225 cases. , 1984, Mayo Clinic proceedings.

[7]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[8]  Hans-Joachim Schäfers,et al.  A new approach to the assessment of aortic cusp geometry. , 2006, The Journal of thoracic and cardiovascular surgery.

[9]  L. Miller,et al.  Partial aortic valve fusion induced by left ventricular assist device. , 2000, The Annals of thoracic surgery.

[10]  M. Oz,et al.  Surgical management of valvular disease in patients requiring left ventricular assist device support. , 2001, The Annals of thoracic surgery.

[11]  Igor D Gregoric,et al.  Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  James O. Mudd,et al.  Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  J Timothy Baldwin,et al.  Executive summary for the National Heart, Lung, and Blood Institute Working Group on next generation ventricular assist devices for destination therapy. , 2005, Seminars in thoracic and cardiovascular surgery.

[14]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[15]  W. M. Swanson,et al.  Dimensions and Geometric Relationships of the Human Aortic Value as a Function of Pressure , 1974, Circulation research.

[16]  O. Frazier,et al.  Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.